Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study

BACKGROUND: All authorities recommend against prostate specific antigen (PSA) screening in men 75 years and older. However, some primary care physicians (PCPs) continue to have high rates of PSA, with large variation in testing. We assessed the tests, treatments, and payments for prostate cancer car...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanwar, Preeti, Lin, Yu-Li, Kuo, Yong-Fang, Goodwin, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715293/
https://www.ncbi.nlm.nih.gov/pubmed/26772175
http://dx.doi.org/10.1186/s12913-016-1265-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715293/
https://www.ncbi.nlm.nih.gov/pubmed/26772175
http://dx.doi.org/10.1186/s12913-016-1265-1

Ejemplares similares